Suchbegriffe: REAL-WORLD STUDY, . Treffer: 12
Garden, GL; Fan, KS; Paterson, M; Shojaee-Moradie, F; Borg, Inguanez, M; Manoli, A; Edwards, V; Lee, V; Frier, BM; Hutchison, EJ; Maher, D; Mathieu, C; Mitchell, SJ; Heller, SR; Roberts, GA; Shaw, KM; Koehler, G; Mader, JK; King, BR; Russell-Jones, DL, , EASA, Diabetes, Consortium
Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational real-world study.
Diabetologia. 2025; 68(1):52-68
Doi: 10.1007/s00125-024-06295-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ebenbichler, C; Drexel, H; Hanusch, U; Toplak, H; Dhalwani, NN; Bridges, I; Hoelzl, R; Hemetsberger, M; Ray, KK
Evolocumab effectiveness in the real-world setting: Austrian data from the pan-European observational HEYMANS study.
Wien Klin Wochenschr. 2024; 136(3-4): 77-86.
Doi: 10.1007/s00508-023-02245-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Richtig, E; Nguyen, VA; Koelblinger, P; Wolf, I; Kehrer, H; Saxinger, W; Ressler, JM; Weinlich, G; Meyersburg, D; Hafner, C; Jecel-Grill, E; Kofler, J; Lange-Asschenfeldt, B; Weihsengruber, F; Rappersberger, K; Svastics, N; Gasser, K; Seeber, A; Kratochvill, F; Nagler, S; Mraz, B; Hoeller, C
Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial.
Melanoma Res. 2023;
Doi: 10.1097/CMR.0000000000000948
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Søholm, U; Broadley, M; Zaremba, N; Divilly, P; Baumann, PM; Mahmoudi, Z; Martine-Edith, G; Mader, JK; Cigler, M; Brøsen, JMB; Vaag, A; Heller, S; Pedersen-Bjergaard, U; McCrimmon, RJ; Renard, E; Evans, M; de, Galan, B; Abbink, E; Amiel, SA; Hendrieckx, C; Speight, J; Choudhary, P; Pouwer, F, , Hypo-RESOLVE, consortium
The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app.
Diabetologia. 2024; 67(10):2160-2174
Doi: 10.1007/s00125-024-06233-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Doleschal, B; Taghizadeh, H; Lentner, T; Riedl, JM; Granitzer, J; Morariu, D; Decker, J; Aichberger, KJ; Webersinke, G; Kirchweger, P; Petzer, A; Rumpold, H
Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer.
ESMO Open. 2023; 8(6):102064
Doi: 10.1016/j.esmoop.2023.102064
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lurz, P; Besler, C; Schmitz, T; Bekeredjian, R; Nickenig, G; Möllmann, H; von, Bardeleben, RS; Schmeisser, A; Atmowihardjo, I; Estevez-Loureiro, R; Lubos, E; Heitkemper, M; Huang, D; Lapp, H; Donal, E, , bRIGHT, PAS, Principal, Investigators
Short-Term Outcomes of Tricuspid Edge-to-Edge Repair in Clinical Practice.
J Am Coll Cardiol. 2023; 82(4):281-291
Doi: 10.1016/j.jacc.2023.05.008
Web of Science
PubMed
FullText
FullText_MUG
Schumann, K; Mauch, C; Klespe, KC; Loquai, C; Nikfarjam, U; Schlaak, M; Akçetin, L; Kölblinger, P; Hoellwerth, M; Meissner, M; Mengi, G; Braun, AD; Mengoni, M; Dummer, R; Mangana, J; Sindrilaru, MA; Radmann, D; Hafner, C; Freund, J; Rappersberger, K; Weihsengruber, F; Meiss, F; Reinhardt, L; Meier, F; Rainer, B; Richtig, E; Ressler, JM; Höller, C; Eigentler, T; Amaral, T; Peitsch, WK; Hillen, U; Harth, W; Ziller, F; Schatton, K; Gambichler, T; Susok, L; Maul, LV; Läubli, H; Debus, D; Weishaupt, C; Börger, S; Sievers, K; Haferkamp, S; Zenderowski, V; Nguyen, VA; Wanner, M; Gutzmer, R; Terheyden, P; Kähler, K; Emmert, S; Thiem, A; Sachse, M; Gercken-Riedel, S; Kaune, KM; Thoms, KM; Heinzerling, L; Heppt, MV; Tratzmiller, S; Hoetzenecker, W; Öllinger, A; Steiner, A; Peinhaupt, T; Podda, M; Schmid, S; Wollina, U; Biedermann, T; Posch, C
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.
J Eur Acad Dermatol Venereol. 2023; 37(5):894-906
Doi: 10.1111/jdv.18779
Web of Science
PubMed
FullText
FullText_MUG
Mader, JK; Gölz, S; Bilz, S; Bramlage, P; Danne, T
Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300).
BMJ Open Diabetes Res Care. 2022; 10(4):
Doi: 10.1136/bmjdrc-2022-002898
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Müller, M; Posch, F; Kiem, D; Barth, D; Horvath, L; Stotz, M; Schaberl-Moser, R; Pichler, M; Greil, R; Jost, PJ; Seeber, A; Amann, A; Schlick, K; Gerger, A; Riedl, JM
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.
Ther Adv Med Oncol. 2021; 13:17588359211039930
Doi: 10.1177/17588359211039930
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
van Akkooi, ACJ; Haferkamp, S; Papa, S; Franke, V; Pinter, A; Weishaupt, C; Huber, MA; Loquai, C; Richtig, E; Gokani, P; Öhrling, K; Louie, KS; Mohr, P
A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB-IVM1a Melanoma in Four European Countries.
Adv Ther. 2021;
Doi: 10.1007/s12325-020-01590-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zweiker, R; Aichinger, J; Metzler, B; Lang, I; Wallner, E; Delle-Karth, G
Ranolazine: impact on quality of life in patients with stable angina pectoris, results from an observational study in Austria - the ARETHA AT study.
Wien Klin Wochenschr. 2019; 131(7-8):165-173
Doi: 10.1007/s00508-019-1481-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Micari, A; Brodmann, M; Keirse, K; Peeters, P; Tepe, G; Frost, M; Wang, H; Zeller, T; IN.PACT Global Study Investigators
Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.
JACC-CARDIOVASC INTE. 2018; 11(10): 945-953.
Doi: 10.1016/j.jcin.2018.02.019
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG